High doses of statin drugs – cholesterol-lowering medications such as Lipitor, Crestor, and Zocor – could bring relieve to people with macular degeneration. The findings were discovered as a result of a study in Harvard Medical School. Your research aimed to explore the link between statin drugs in people with dry form of age-related macular degeneration (AMD).
Macular degeneration is a widespread eye illness affecting over One humdred and fifty million people globally. There are two forms of AMD: the wet form along with the dry form. This dry form is much more prevalent, accounting for Eighty-five percent of cases. Unfortunately, there is no effective strategy for the dry AMD, unlike its less common version, the wet kind. As a result, the dry-form macular weakening continues to be the main cause of loss of sight in the Western world. The deterioration of vision can be caused by the fat debris under the retina.
The study involved 23 participants suffering from dry-form AMD. The patients ingested a high dose regarding atorvastatin (also known as Lipitor). Ten sufferers experienced some advancement in their vision, since the fat deposits under the retina faded.
“We found that rigorous doses of statins have the potential for clearing up your lipid [fat] debris that could lead to vision disability in a subset of patients with macular deterioration,” shared Dr. Joan Miller, chair of ophthalmology with Harvard Medical School and also chief of ophthalmology with Massachusetts Eye as well as Ear Infirmary and Boston General Hospital. ( space ) “We hope that this offering preliminary clinical trial may be the foundation for an successful treatment for millions of sufferers afflicted with AMD.”
The treatment time period took between one year and a year and a half to produce positive results. There was no successful efforts to get rid of the fat within the retina prior to this study. The achievements of the present trial court warrants high hopes for the longer term AMD treatment.
Study co-author Dr. Demetrios Vavvas claimed, “It may be possible to ultimately have a treatment not only arrests the condition but also reverses it is damage and adds to the visual acuity in certain patients.”
A larger examine of the effect which the high-dose statin treatment has on dry-form AMD clients will be the next step within this research.
“This is a very accessible, FDA-approved drug that we have tremendous experience with,” Vavvas explained. “An incredible number of patients take it for high cholesterol and heart related illnesses, and based on our early results, we presume it offers the potential to end progression of this disease, although possibly even to restore perform in some patients together with dry AMD.”